The 2026 AAD Annual Meeting in Denver covered pediatric acne and rosacea in children and teens. Rosacea means lasting facial redness with bumps, and Dr.
Dawn Eichenfield showed why early diagnosis matters because childhood disease differs from adult disease. According to the American Academy of Dermatology, the meeting ran March 27-31, 2026, as the full clinical and academic gathering meeting highlights. This briefing translates that focus into practical choices for parents and teen patients.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why early diagnosis matters in kids
- How do doctors separate rosacea from acne?
- Which treatments suit children?
- What about skin of color and new drugs?
Why early diagnosis matters in kids
Pediatric rosacea often starts between ages 4 and 8. Red cheeks can look cute, so families and clinicians may miss it.
Breakouts that overlap with acne add to the delay. According to HCPLive reporting on Maui Derm 2026, childhood rosacea can persist into adulthood and eye disease needs treatment to prevent serious harm case review. Early action protects skin, vision, and confidence.
How do doctors separate rosacea from acne?
Childhood rosacea shares signs with acne vulgaris, perioral dermatitis, seborrheic dermatitis, and demodicosis. Redness, papules, and pustules appear in several of these conditions.
Careful differential diagnosis is therefore critical. A Dermatology Times review notes an eye exam is warranted when a child has papules and pustules. Parents can track these patterns before the visit: Bring photos of flares, a list of skin products, and eye symptoms.
- lasting cheek redness plus flushing or visible vessels
- acne-like bumps that do not respond as expected
- eye irritation, redness, styes, or light sensitivity
Which treatments suit children?
For mild pediatric rosacea, care uses topical metronidazole or azelaic acid plus eyelid hygiene. Moderate to severe disease uses oral erythromycin or azithromycin. Tetracyclines are avoided under age 8 to 9. According to the American Academy of Dermatology via Newswise, acne guidance strongly favors topical benzoyl peroxide, topical retinoids, and antibiotic combinations updated acne guidance.
Retinoids include adapalene, tretinoin, tazarotene, and trifarotene. Stewardship means pairing antibiotics with benzoyl peroxide and limiting systemic duration. Ask the dermatologist what step matches severity, age, and eye signs. Ask how long to use each product and when to return.
What about skin of color and new drugs?
According to AJMC, a new March 28 session on inflammatory skin diseases in skin of color offered clinical pearls for acne, rosacea, atopic dermatitis, psoriasis, and vitiligo. Redness can look different in darker skin, so texture, bumps, warmth, and eye signs carry extra weight. Families can ask for examples relevant to their child's tone.
Evidence limits remain. According to Journey Medical, low-dose oral minocycline Emrosi won FDA approval in November 2024 only for inflammatory rosacea in adults. Most pediatric rosacea care is still adapted from adult guidelines with few pediatric trials. Do not assume a new adult rosacea drug fits a child.
You Might Also Like
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: When to Seek Care for Pediatric Dermatology Patients
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Scarring and Pigment-Change Questions for Pediatric Dermatology Patients
- Individualized Pediatric Acne Care Discussed at AAD 2026: A Source-Checked 2026 Briefing for Parents of Children With Acne